Smoking Among UK Students at Historic Low: NHS Digital

Sep.07.2022
Smoking Among UK Students at Historic Low: NHS Digital
Smoking among school students in England has hit a record low at 3%, according to NHS Digital. However, over 20% of 15-year-old girls now use e-cigarettes, which is reminiscent of smoking levels over a decade ago. The statistics also show progress in reducing underage drinking and drug use.

Newly released statistics from NHS Digital have revealed that the proportion of smoking students has hit a record low of 3%. However, alarmingly, over 20% of 15-year-old girls are now using e-cigarettes, bringing to mind the smoking levels seen over a decade ago. This data suggests a worrying trend towards a new form of nicotine addiction among young people. Photo credit: David Jones/PA.


A study has revealed that in 2021, 21% of 15-year-old girls admit to currently using electronic cigarettes, more than twice the amount recorded by NHS Digital in 2018 (10%). The percentage of girls using e-cigarettes is 7 percentage points higher than their male peers of the same age.


The 2021 report on smoking, drinking, and drug use among young people in England shows a decrease in the percentage of students who self-report as smokers from 5% in 2018 to 3% in 2021, reaching an all-time low. As of 2021, less than one-eighth of secondary school students (12%) have ever smoked, which is the lowest number since comparable records began in 1982.


The number of people using electronic cigarettes has reached a historical high. In 2021, 9% of students have tried e-cigarettes, which is the highest number on record, compared to 6% in 2018. Girls aged 15 are most likely to do so, with over one-fifth of people reporting current use and 12% saying they use e-cigarettes frequently. The last time regular smoking rates were this high among 15-year-old girls was in 2010, when 14% reported being regular smokers.


However, the study also revealed progress in reducing alcohol and drug use. According to new data released by NHS Digital, only 18% of 11 to 15-year-old teenagers in England reported having used drugs by 2021, down from 24% in 2018. Last year, only 40% of students reported having drunk alcohol, down from 44% in both 2018 and 2016.


According to data, high school students with stronger social skills- those who frequently interact with people outside of their family or school- are more likely to have tried illegal drugs, alcohol, or smoking compared to those who rarely meet others. Among those who interact with people outside of their family or school on a daily basis, nearly one-fifth (19%) have used drugs in the past month. In contrast, 8% of those who socialize outside of their home or school a few times a week and 5% of those who only meet with people outside of their home or school once a week have used drugs in the past month. Among those who have not met anyone in the past month, only 2% have used drugs.


According to statistical data, Covid-19 may have played a role in the decrease in drug usage, as the early 2021 restrictions may have limited young people's opportunities to socialize outside of school. The proportion of students who have tried nitrous oxide (known as laughing gas) has decreased significantly. In 2021, only 3% of students had tried it, a decrease of 2.8 percentage points since 2018. The proportion of high school students who have tried glue and solvents has decreased by 2.2 percentage points to 6.8%, while cocaine usage has decreased from 1.8% to 1.4%.


Reducing drug use, alcohol consumption and smoking may have a positive impact on the mental health and well-being of young people. Last month, more than half of children who used drugs reported low levels of happiness during that time, while only 26% of children who did not smoke, drink or use drugs reported feeling happy.


Statement


This article is compiled from third-party information and is intended for industry discussion and learning purposes.


This article does not necessarily reflect the viewpoint of 2FIRSTS and we cannot confirm the authenticity and accuracy of its content. The translation of this article is solely for the purpose of industry exchange and research.


Due to limitations in our translation abilities, the translated version of this article may not accurately reflect the original text. Please refer to the original article for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign issues and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Japan Tobacco Inc. (JT) has introduced the Ploom AURA Glacier White heated tobacco device in Japan, adding a new color option to the existing Ploom AURA lineup. The device maintains the existing SMART HEATFLOW technology and HEAT SELECT SYSTEM with four heating modes, while expanding the ecosystem through new accessories including front panels, back covers, a car holder and wireless charging covers. The product entered pre-sale in Japan on June 30, 2026, followed by broader retail availability from July 7.
Aug.03
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22